ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,902Medicare Part D Prescriptions Filled, Including Refills

Rank: 33 out of 617

$876K Total Retail Price of All Prescriptions

Rank: 11 out of 617

702 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 702 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 702 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

0% of this provider’s 9,519 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
WARFARIN SODIUM 466 342 1 7
LEVOTHYROXINE SODIUM 450 347 2 1
HYDROCODONE-ACETAMINOPHEN 392 290 S3 3 8
OMEPRAZOLE 375 275 4 3
SIMVASTATIN 370 330 5 2
LISINOPRIL 357 248 6 5
FUROSEMIDE 316 237 7 4
METOPROLOL TARTRATE 275 194 8 11
AMLODIPINE BESYLATE 264 188 9 6
SERTRALINE HCL 210 165 10 20
HYDROCHLOROTHIAZIDE 208 174 11 13
CITALOPRAM HBR 203 131 12 18
METFORMIN HCL 199 144 13 9
METOPROLOL SUCCINATE 181 135 14 12
PREDNISONE 175 123 15 31
GABAPENTIN 168 106 16 16
ATENOLOL 161 144 17 17
PRAVASTATIN SODIUM 154 89 18 21
TRAMADOL HCL 153 99 19 15
DONEPEZIL HCL 153 148 19 30
POTASSIUM CHLORIDE 148 81 21 10
ZOSTAVAX 140 117 22 99
NAMENDA 129 114 23 35
OXYCODONE-ACETAMINOPHEN 122 49 S2 24 93
TRIAMTERENE-HCTZ 116 90 25 47
LOSARTAN POTASSIUM 114 99 26 22
QUETIAPINE FUMARATE 114 67 26 78
ALENDRONATE SODIUM 114 77 26 25
METOCLOPRAMIDE HCL 110 40 29 125
ATORVASTATIN CALCIUM 108 85 30 14
LANTUS 96 43 31 39
FAMOTIDINE 96 54 31 54
FENOFIBRATE 93 71 33 58
ONDANSETRON HCL 91 45 34 234
TRAZODONE HCL 91 70 34 51
TAMSULOSIN HCL 90 66 36 26
ZOLPIDEM TARTRATE 89 54 37 23
ALLOPURINOL 87 66 38 27
DIVALPROEX SODIUM 86 68 39 111
CIPROFLOXACIN HCL 85 65 40 60
FENTANYL 84 23 S2 41 45
LISINOPRIL-HYDROCHLOROTHIAZIDE 84 76 41 29
RISPERIDONE 82 45 43 71
LEVETIRACETAM 79 24 44 166
FLUTICASONE PROPIONATE 78 64 45 36
PANTOPRAZOLE SODIUM 77 59 46 37
FINASTERIDE 75 73 47 104
GLIMEPIRIDE 73 53 48 33
IPRATROPIUM BROMIDE 72 68 49 136
CARVEDILOL 70 45 50 19
PHENYTOIN SODIUM EXTENDED 70 17 50 121
CARBIDOPA-LEVODOPA 70 58 50 69
NOVOLOG 70 39 50 137
SODIUM CHLORIDE 69 0 54 238
ADVAIR DISKUS 64 59 55 38
DIGOXIN 64 55 55 48
LIDODERM 62 39 57 188
SPIRONOLACTONE 61 58 58 42
ESCITALOPRAM OXALATE 61 47 58 65
RANITIDINE HCL 60 19 60 40
IPRATROPIUM-ALBUTEROL 59 23 61 151
MELOXICAM 57 51 62 24
ENOXAPARIN SODIUM 56 52 63 302
NITROFURANTOIN MONO-MACRO 55 42 64 205
CLOPIDOGREL 55 47 64 53
CYMBALTA 55 19 64 49
DILTIAZEM ER 55 50 64 81
LEVOFLOXACIN 52 40 68 89
VANCOMYCIN HCL 51 0 69 321
VENLAFAXINE HCL ER 50 39 70 76
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 17, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.